Suppr超能文献

系统评价:质子泵抑制剂对消化道微生物组的影响——来自下一代测序研究的证据。

Systematic review: the effects of proton pump inhibitors on the microbiome of the digestive tract-evidence from next-generation sequencing studies.

机构信息

Department of Medicine II, University Hospital, LMU Munich, Munich, Germany.

Department of Gastroenterology, Hepatology and Infectious Diseases, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.

出版信息

Aliment Pharmacol Ther. 2020 Mar;51(5):505-526. doi: 10.1111/apt.15604. Epub 2020 Jan 28.

Abstract

BACKGROUND

Proton pump inhibitors (PPI) are widely used to treat acid-related disorders of the upper gastrointestinal tract. However, large observational studies have raised concerns about PPI-associated adverse events. In recent years, data from next-generation sequencing studies suggested that PPIs affect the composition of the intestinal microbiota, while a balanced gut microbiome is essential for maintaining health.

AIM

To review the available evidence from next-generation sequencing studies on the effect of PPIs on the intestinal microbiome and to discuss possible implications of PPI-induced dysbiosis in health and disease.

METHODS

A systematic review was conducted following the recommendations of the Preferred Reporting Items for Systematic reviews and Meta-Analyses statement. A PubMed query yielded 197 results. 19 publications met the prespecified eligibility criteria.

RESULTS

Twelve observational study cohorts with 708 PPI users and 11 interventional cohorts with 180 PPI users were included in the review. In most studies, PPI treatment did not affect microbiological richness and diversity, but was associated with distinct taxonomic alterations: In the upper gastrointestinal tract, PPI users showed overgrowth of orally derived bacteria, mostly Streptococcaceae (findings based on six independent cohorts with 126 PPI users). In faecal samples, PPIs increased multiple taxa from the orders Bacillales (eg, Staphylococcaceae), Lactobacillales (eg, Enterococcaceae, Lactobacillaceae, Streptococcaceae) and Actinomycetales (eg, Actinomycetaceae, Micrococcaceae), the families Pasteurellaceae and Enterobacteriaceae and the genus Veillonella. Taxa decreased by PPIs include Bifidobacteriaceae, Ruminococcaceae, Lachnospiraceae and Mollicutes (findings in faecal samples based on 19 independent cohorts with 790 PPI users).

CONCLUSION

PPI use is associated with moderate alterations to upper and distal gut microbiota. The available data suggest that PPI-induced hypochlorhydria facilitates colonization of more distal parts of the digestive tract by upper gastrointestinal microbiota.

摘要

背景

质子泵抑制剂(PPI)被广泛用于治疗上消化道的酸相关疾病。然而,大型观察性研究引起了对 PPI 相关不良事件的关注。近年来,下一代测序研究的数据表明,PPIs 会影响肠道微生物群的组成,而平衡的肠道微生物群对于维持健康至关重要。

目的

综述下一代测序研究中关于 PPI 对肠道微生物群影响的现有证据,并讨论 PPI 诱导的肠道微生物失调对健康和疾病的可能影响。

方法

根据系统评价和荟萃分析的首选报告项目的建议进行系统综述。对 PubMed 进行查询,得到 197 项结果。19 篇出版物符合预先规定的入选标准。

结果

该综述纳入了 12 项观察性研究队列,其中 708 名 PPI 使用者和 11 项干预性研究队列,其中 180 名 PPI 使用者。在大多数研究中,PPI 治疗并未影响微生物学的丰富度和多样性,但与明显的分类学改变有关:在上消化道,PPI 使用者表现出口腔来源细菌的过度生长,主要是链球菌科(基于 6 项涉及 126 名 PPI 使用者的独立队列的研究结果)。在粪便样本中,PPIs 增加了多个来自芽孢杆菌目(例如葡萄球菌科)、乳杆菌目(例如肠球菌科、乳杆菌科、链球菌科)和放线菌目(例如放线菌科、微球菌科)、巴斯德氏菌科和肠杆菌科以及韦荣球菌属的分类群。PPIs 减少的分类群包括双歧杆菌科、瘤胃球菌科、毛螺菌科和柔膜体纲(基于 19 项涉及 790 名 PPI 使用者的独立队列的粪便样本研究结果)。

结论

PPI 使用与上消化道和远端肠道微生物群的中度改变有关。现有数据表明,PPI 诱导的低胃酸分泌有助于上消化道微生物定植于消化道的更远端部位。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验